A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A study of brain activity in courting zebra finches could help neuroscientists understand what happens in our brains when they shift gears as priorities and opportunities change.
Columbia researchers tracked how current language models, such as ChatGPT, mistake nonsense sentences as meaningful. Will analyzing their errors help us understand the way people think?
ADScreen, a speech-processing algorithm developed at Columbia Nursing, is now being tested in a clinical trial to see if it can help health care workers identify patients with Alzheimer's earlier.
Biomedical engineer Santiago Correa uses his expertise in nanotechnology to create injectable biomaterials that reprogram the body’s immune system to fight cancer, autoimmune disease, and infection.
A new study that uncovers the original role of CRISPR’s scissors answers an evolutionary mystery and could lead to the discovery of better gene editing tools.
A study involving Columbia researchers finds that malaria parasites in Africa have developed resistance to artemisinin drugs, which could worsen malaria’s impact if partner drugs fail in the future.
Health care workers, including registered nurses and support workers, are at increased risk of suicide compared with workers in other fields, Columbia researchers have found.
When all evidence of cancer disappeared from Catherine Spina’s patient after radiation of a single metastasis, she became convinced that radiotherapy may be key to a new treatment approach.